Zephyrnet Logo

Medical Devices

Guidance Reveals How NMPA Inspects Your Clinical Trial Institution

NMPA announced the “Measures for Supervision and Inspection of Medical Device Clinical Trial Institutions (Trial)” on March 12, 2024, for feedback, along with the...

21 Class III Devices Exempted for Clinical Trial: Faster Market Access for Surgical Equipment in Cardio, Neuro, Ortho, Aesthetic and Dental Applications

NMPA issued the “Clinical Pathway Recommendations for Certain Categories of Medical Devices” today on March 18, 2024. The document suggests manufacturers how to choose...

Strong Fourth Quarter Powers 2023 Kelyniam Financials | BioSpace

CANTON, Conn., March 17, 2024 /PRNewswire/ -- Kelyniam Global (OTC:KLYG), a maker of custom cranial implants, today announced results for its year ended December...

ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call | BioSpace

PLEASANTON, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, announced today...

How Post-Market Surveillance Enhances Medical Device Safety

Understanding Post-Market Surveillance:In the fast-paced world of medical technology, the journey of a medical device doesn’t end with regulatory approval. It continues into the...

Asensus Surgical, Inc. Schedules Fourth Quarter and Full Year 2023 Financial and Operating Results Conference Call for March 21, 2024 | BioSpace

RESEARCH TRIANGLE PARK, N.C., March 15, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the...

Latest Intelligence

spot_img
spot_img